Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Preclinical data reported for new irofulven analogue MGI-4184

April 24, 2007

Sirtex Medical to sponsor FAST trial

April 24, 2007

Potent and selective c-Met inhibitor described at AACR by Merck team

April 23, 2007

MAb targeting DR5 induces apoptosis and tumor regression without toxicity

April 23, 2007

Full FDA approval for DepoCyt for lymphomatous meningitis

April 23, 2007

BGC-945 emerges as a tumor-targeted agent with minimal toxicity

April 23, 2007

European orphan drug designation for PDX in peripheral T-cell lymphoma

April 23, 2007

Indevus seeks to return Valstar to U.S. market

April 23, 2007

Novacea gains additional rights to AQ4N

April 23, 2007

Genta plans new phase III study of Genasense in advanced melanoma

April 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...